期刊文献+

ω-3多不饱和脂肪酸在支气管哮喘中的应用进展

下载PDF
导出
摘要 近年来有许多关于ω-3多不饱和脂肪酸在免疫调节方面的研究,哮喘的发病和免疫机制密切相关,也得到了许多学者的重视和深入的探讨,本文对近年来有关ω-3多不饱和脂肪酸在支气管哮喘中的应用进行综述。
作者 马旺
出处 《中国实用医药》 2011年第35期245-246,共2页 China Practical Medicine
  • 相关文献

参考文献14

  • 1Calder PC. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr, 2006, 83 ( 6 Suppl ) : 1505-1519.
  • 2Hao W, Wong OY, Liu X, et al. o~-3 fatty acids suppress inflammatory cytokine production by macrophages and hepatocytes. J Pediatr Surg, 2010,45(12) :2412-2418.
  • 3张俊杰,周克元,蔡春.n-3脂肪酸代谢产物抗炎作用的研究进展[J].生物化学与生物物理进展,2011,38(1):20-27. 被引量:6
  • 4陈灏珠,林果为.支气管哮喘.实用内科学.第13版.上海:人民卫生出版社,2009:1730-1733.
  • 5Bilal S, Haworth O, Wu L, et al. Fat-1 transgenic mice with elevated omega-3 fatty acids are protected from allergic airway responses. Biochim Biophys Acta,2011,1812(9) :1164-1169.
  • 6王强,罗运春,周晓聪,黄娟.n-3多不饱和脂肪酸对哮喘小鼠白三烯B4及5脂氧合酶基因表达的影响[J].实用医学杂志,2007,23(8):1131-1133. 被引量:8
  • 7Leemans J, Cambier C, Chandler T, et al. Prophylactic effects of omega-3 polyunsaturated fatty acids and luteolin on airway hyperresponsiveness and inflammation in cats with experimentally-induced asthma. Vet J, 2010,184(1) :111-114.
  • 8Aoki H, Hisada T, Ishizuka T, et al. Resolvin E1 dampens airway inflammation and hyperresponsiveness in a murine model of asthma. Biochem Biophys Res Commun, 2008,367 (2) :509-515.
  • 9Levy BD, Kohli P, Gotlinger K, et al. Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness. J Immunol, 2007,178( 1 ) :496-502.
  • 10Nagakura T, Matsuda S, Shichijyo K, et al. Dietary supplementation with fish oil rich in omega-3 polyunsaturated fatty acids in children with bronchial asthma. Eur Respir J, 2000, 16 ( 5 ) : 861-865.

二级参考文献48

  • 1王华,陈艳波,张孔.白三烯受体拮抗剂对哮喘患者血清IL-5水平及气道高反应性的影响[J].实用医学杂志,2005,21(21):2392-2395. 被引量:29
  • 2石俊,安京华,姚侠,尹曾.廿烷五烯酸影响机体免疫机制的研究与应用[J].中国临床康复,2006,10(20):143-145. 被引量:3
  • 3彭秋莹,陈爱欢.白三烯研究进展及其在婴幼儿喘息性疾病中的作用[J].中华儿科杂志,2006,44(7):553-556. 被引量:94
  • 4American Thoracic Society guidelines for methacholine and exercise challenge testing-1999. Am J Respir Crit Care Med, 2000, 161: 309-329.
  • 5American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med, 1995,152 : 1107-1136.
  • 6Merched A J, Ko K, Gotlinger K H, et al. Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators. Faseb J, 2008, 22(10): 3595-3606.
  • 7Krishnarnoorthy S, Recchiuti A, Chiang N, et ol. Resolvin D1 binds human phagocytes with evidence for proresolving receptors, Proc Natl Acad Sci USA, 107(4): 1660-1665.
  • 8Duffield J S, Hong S, Vaidya V S, etal. Resolvin D series and protectin D1 mitigate acute kidney injury. J Imrnunol, 2006, 177(9): 5902-5911.
  • 9Spite M, Summers L, Porter T F, et al. Resolvin D1 controls inflammation initiated by glutathione-lipid conjugates formed during oxidative stress. British J Pharmacology, 2009, 158 (4): 1062-1073.
  • 10Levy B D, Kohli P, Gotlinger K, et ol. Protectin DI is generated in asthma and dampens airway inflammation and hyperresponsiveness. J Imrnunol, 2007, 178(1): 496-502.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部